Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Ana Maria Vega"'
Autor:
Cristian A. Bergmann, Sebastian Beltran, Ana Maria Vega-Letter, Paola Murgas, Maria Fernanda Hernandez, Laura Gomez, Luis Labrador, Bastián I. Cortés, Cristian Poblete, Cristobal Quijada, Flavio Carrion, Ute Woehlbier, Patricio A. Manque
Publikováno v:
Cells, Vol 11, Iss 9, p 1503 (2022)
Mesenchymal stem cells (MSC) have emerged as a promising tool to treat inflammatory diseases, such as inflammatory bowel disease (IBD), due to their immunoregulatory properties. Frequently, IBD is modeled in mice by using dextran sulfate sodium (DSS)
Externí odkaz:
https://doaj.org/article/de383cfc8e13458d81d27fcb9b1e7fce
Autor:
Daniela N Urrutia, Pablo Caviedes, Rodrigo Mardones, José J Minguell, Ana Maria Vega-Letter, Claudio M Jofre
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0213032 (2019)
Mesenchymal stem cells (MSCs) can trans/differentiate to neural precursors and/or mature neurons and promote neuroprotection and neurogenesis. The above could greatly benefit neurodegenerative disorders as well as in the treatment of post-traumatic a
Externí odkaz:
https://doaj.org/article/a7ede652923a44aba22664e55e0b2637
Autor:
Cynthia Aylín García-Guerrero, Paloma Fuentes, María Jesús Araya, Farida Djouad, Patricia Luz-Crawford, Ana María Vega-Letter, Claudia Altamirano
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Mesenchymal stem/stromal cells (MSCs) have emerged as a promising tool in the field of regenerative medicine due to their unique therapeutic properties as they can differentiate into multiple cell types and exert paracrine effects. However,
Externí odkaz:
https://doaj.org/article/0aad8964e85b466cab734d57f26d76ff
Autor:
Lucas Val-Terron, J. Joaquin Escudero-Garzas, Luis Perez-Roca, Ana Maria Vega-Viejo, Angel Alves-Gonzalez
Publikováno v:
2022 18th International Conference on Wireless and Mobile Computing, Networking and Communications (WiMob).
Autor:
Stephen Jan, Ana Maria Vega, Jie Jiang, Stephen W.L. Lee, Yong Huo, Hyo-Soo Kim, Stuart J. Pocock, Tiong Kiam Ong, Chee Tang Chin, Rungroj Krittayaphong, Vo T. Nhan, Nobuya Hayashi, Ángeles Alonso-Garcia, Jitendra P.S. Sawhney
Publikováno v:
International Journal of Cardiology. 315:1-8
Aims Approximately half of cases of cardiovascular disease (CVD) worldwide occur in Asia, with acute coronary syndrome (ACS) a leading cause of mortality. Long-term ACS-related outcomes data in Asia are limited. This analysis examined 2-year ACS-rela
Autor:
Yong Huo, Stephen W.L. Lee, Bo Zheng, Nobuya Hayashi, Tiong Kiam Ong, Hyo-Soo Kim, Jitendra P.S. Sawhney, Vo T. Nhan, Rungroj Krittayaphong, Angeles Alonso Garcia, Chee Tang Chin, Ana Maria Vega, Jie Jiang, Stephen Jan, Stuart J. Pocock
Publikováno v:
Clinical Cardiology
Background Despite guideline recommendations, dual antiplatelet therapy (DAPT) is frequently used for longer than 1 year after an acute coronary syndrome (ACS) event. In Asia, information on antithrombotic management patterns (AMPs), including DAPT p
Autor:
Gutiérrez, Ana Maria Vega1
Publikováno v:
Journal of Business Diversity. 2019, Vol. 19 Issue 4, p120-138. 19p.
Autor:
Jie Jiang, Stuart J. Pocock, Chee Tang Chin, Stephen W.L. Lee, Ana Maria Vega, Frans Van de Werf, Yong Huo, Jesús Medina, Héctor Bueno, Xavier Rossello, Yi Li, Yaling Han
Publikováno v:
American Journal of Cardiovascular Drugs
Background Information is lacking on long-term management of patients with acute coronary syndrome (ACS) and chronic kidney disease (CKD) (estimated glomerular filtration rate [eGFR] < 60 mL/min/1.73 m(2)). Objectives Our objectives were to describe
Autor:
Jose C. Nicolau, Gema Requena, Christopher B. Granger, Andrew Maguire, Tigris Study Investigators, Richard Grieve, Stefan Blankenberg, Stuart J. Pocock, David Brieger, Dirk Westermann, Tabassome Simon, Satoshi Yasuda, Ji Yan Chen, Shaun G. Goodman, Ana Maria Vega
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
The long-term progression of coronary artery disease as defined by the natural disease course years after a myocardial infarction (MI) is an important but poorly studied area of clinical research. The long-Term rIsk, clinical manaGement, and healthca
Autor:
Carolina Pradenas, Noymar Luque-Campos, Karina Oyarce, Rafael Contreras-Lopez, Felipe A. Bustamante-Barrientos, Andrés Bustos, Felipe Galvez-Jiron, María Jesús Araya, Catalina Asencio, Raúl Lagos, Yeimi Herrera-Luna, Daouda Abba Moussa, Charlotte Nicole Hill, Eliana Lara-Barba, Claudia Altamirano, Alexander Ortloff, Yessia Hidalgo-Fadic, Ana María Vega-Letter, María de los Ángeles García-Robles, Farida Djouad, Patricia Luz-Crawford, Roberto Elizondo-Vega
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract Background The metabolic reprogramming of mesenchymal stem/stromal cells (MSC) favoring glycolysis has recently emerged as a new approach to improve their immunotherapeutic abilities. This strategy is associated with greater lactate release,
Externí odkaz:
https://doaj.org/article/c416d31c38b04152b5d78e8d3cebc75a